EMAIL THIS PAGE TO A FRIEND

Investigative ophthalmology & visual science

The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells.


PMID 23611999

Abstract

Without therapeutic intervention, corneal neovascularization rapidly compromises visual acuity, and is a leading cause of blindness. Artesunate was reported to inhibit angiogenesis in tumors, although, the effects of artesunate on nontumor angiogenesis have not been investigated. This study was designed to investigate the effect of artesunate on corneal neovascularization and delineate its underlying mechanism of action. Rats with alkali-burned corneas were treated with artesunate for 11 days. Corneal neovascularization was evaluated by measuring the length and area of corneal vasculature in the rats. Apoptotic cells were stained with AnnexinV and propidine iodide (PI), and measured with flow cytometry analysis. Apoptosis-related and p38 mitogen-activated protein kinases (p38MAPK) signaling were evaluated by Western blot analysis. Artesunate significantly inhibited corneal neovascularization and inflammation via specifically inducing apoptosis of vascular endothelial cells. In vascular endothelial cells, artesunate increased the Bax/Bcl-2 ratio, reduced mitochondrial membrane potential, stimulated release of cytochrome C, and cleavage of caspase 9 and 3, suggesting that the mitochondrial apoptotic pathway was involved. Artesunate activated p38MAPK, and specific p38MAPK inhibitors suppressed artesunate-induced apoptosis in endothelial cells. Reactive oxygen species (ROS) levels were increased by artesunate. N-acetyl-L-cysteine blocked p38MAPK activation and protected endothelial cells from artesunate-induced apoptosis. Ferrous salt increased ROS levels and elevated the cytotoxic effect of artesunate on endothelial cells, while the iron chelating agent deferoxamine decreased ROS levels and artesunate-induced apoptosis. Artesunate had no effect on expression of Fas, Fas Ligand, or caspase 8 cleavage. These results suggest that artesunate induces apoptosis of endothelial cells via an iron/ROS-dependent p38MAPK-mitochondrial pathway.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

223913 Ascarite®, Sodium hydroxide-coated silica, 8-20 mesh
223921 Ascarite®, Sodium hydroxide-coated silica, 20-30 mesh
S8045
Sodium hydroxide, BioXtra, ≥98% (acidimetric), pellets (anhydrous)
HNaO
306576
Sodium hydroxide, pellets, semiconductor grade, 99.99% trace metals basis
HNaO
S5881
Sodium hydroxide, reagent grade, ≥98%, pellets (anhydrous)
HNaO
221465
Sodium hydroxide, ACS reagent, ≥97.0%, pellets
HNaO
367176
Sodium hydroxide, beads, 20-40 mesh, reagent grade, 97%
HNaO
484024
Sodium hydroxide, reagent grade, 97%, flakes
HNaO
71690
Sodium hydroxide, puriss. p.a., ACS reagent, K ≤0.02%, ≥98.0% (T), pellets
HNaO
30620
Sodium hydroxide, puriss. p.a., ACS reagent, reag. Ph. Eur., K ≤0.02%, ≥98%, pellets
HNaO
06203
Sodium hydroxide, puriss., meets analytical specification of Ph. Eur., BP, NF, E524, 98-100.5%, pellets
HNaO
06306
Sodium hydroxide, ≥98.5%, microprills
HNaO
06208
Sodium hydroxide, for the manufacture of mirrors, pellets, Cl <0.001%
HNaO
655104
Sodium hydroxide, reagent grade, 97%, powder
HNaO
901915
Sodium hydroxide, anhydrous, free-flowing, Redi-Dri, reagent grade, ≥98%, pellets
HNaO
415413
Sodium hydroxide solution, 50% in H2O
HNaO
05211
Sodium hydroxide solution, purum, ≥32%
HNaO
30530
Sodium hydroxide solution, ≥20%
HNaO
S8263
Sodium hydroxide solution, 5.0 M
HNaO